Company profile
Home | Sense
We are transforming healthcare by redefining diagnostics. Instrument-free speed, accuracy, mobility, and more.
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Apr 2019 to 30 Jun 2021
Infections that affect patients breathing, such as influenza and respiratory syncytial virus (RSV), cause over 6 million hospital admissions and c.700,000 deaths globally each year. They particularly impact over 65s, under 5s and patients with chronic disease, e.g. COPD. There is an important need to improve the diagnosis and treatment of respiratory illn...
1 May 2017 to 30 Apr 2018
This project is focused on developing a simple product to allow for primary cervical cancer screening tests to be performed in a single medical appointment. The latest state-of-the-art approach to screening involves testing for infection by high-risk human papilloma virus but this currently requires complex and expensive machines which need to be run by s...
1 Jan 2017 to 31 Dec 2018
Infections that affect patients breathing, such as influenza and respiratory syncytial virus (RSV), cause over 6 million hospital admissions and c.700,000 deaths globally each year. There is a need to focus on better diagnosis and treatment of respiratory illnesses including cutting the use of antibiotics when they are not required. Laboratory diagnostic ...
1 Dec 2016 to 31 Mar 2017
Cervical cancer is the leading cause of cancer death in Indian women between the ages of 30 and 69. Only around 3.1% of women undergo screening tests in India versus 77.5% in the UK, a discrepancy meaning that the age standardised mortality rate from this disease is almost 7 times higher in India. This project aims to conduct market research and further e...
1 Nov 2015 to 31 Jan 2017
Colorectal cancer (CRC) is the fourth largest cause of cancer death worldwide, with 694,000 deaths per annum. In the UK it is the second leading cause, with 16,187 deaths in 2012. In current clinical practice, CRC patients are tested for mutations in certain cancer-related genes in order to assess their prognosis and determine eligibility for particular t...
1 May 2015 to 31 Oct 2015
SENSE Biodetection Limited is focused on discovery and development of biological assays and diagnostic tests for research and clinical diagnosis of infections and other diseases. The company has applied for an innovation voucher to obtain crucial expert advice on the design and engineering of its diagnostic testing devices.
1 Oct 2014 to 31 Mar 2016
This project aims to develop new technologies for the diagnosis of influenza and other infectious diseases. Seasonal flu infects 5-20% of the population each year, leading to >3 million serious cases and 250,000-500,000 deaths worldwide. In addition, the risk of new pandemic strains that spread rapidly across the World with devastating consequences is inc...
